Collision-Induced Dissociation of Purine Antiviral Agents: Mechanisms of Ion Formation Using Gas-Phase Hydrogen/Deuterium Exchange and Electrospray Ionization Tandem Mass Spectrometry

Abstract

Electrospray ionization (ESI) and collision-induced dissociation (CID) mass spectra were obtained for two purine nucleoside antiviral agents (acycloguanosine and vidarabine) and one purine nucleotide (vidarabine monophosphate) and for the corresponding compounds in which the labile hydrogens were replaced by deuterium gas-phase exchange. The number of labile hydrogens, x, was determined from a comparison of ESI spectra obtained with N₂ and with ND₃ as the nebulizer gas. CID mass spectra were obtained for [M + H]⁺ and [M – H]⁻ ions and the exchanged analogs, [M(D_x) + D]⁺ and [M(D_x) – D]⁻, produced by ESI using a Sciex API-III^plus mass spectrometer. Compositions of product ions were determined and mechanisms of decomposition elucidated by comparison of the CID mass spectra of the undeuterated and deuterated species. Protonated purine antiviral agents dissociate through rearrangement decompositions of base-protonated [M + H]⁺ ions by cleavage of the glycosidic bonds to give the protonated bases with a sugar moiety as the neutral fragment. Cleavage of the same bonds with charge retention on the sugar moiety gives low abundance ions, due to the low proton affinity of the sugar moiety compared with that of the purine base. CID of protonated purine bases [B + H]⁺ occurs through two major pathways: (1) elimination of NH₃ (ND₃) and (2) loss of NH₂CN (ND₂CN). Minor pathways include elimination of HNCO (DNCO), loss of CO and loss of HCN (DCN). Deprotonated acycloguanosine and vidarabine exhibit the deprotonated base [B – H]⁻ as a major fragment from glycosidic bond cleavage and charge delocalization on the base. Deprotonated vidarabine monophosphate, however, shows predominantly phosphate-related product ions. CID of deprotonated guanine shows two principal pathways: (1) elimination of NH₃ (ND₃) and (2) loss of NH₂CN (ND₂CN). Minor pathways include elimination of HNCO (DNCO), loss of CO and loss of HCN (DCN). The dissociation reactions of deprotonated adenine, however, proceed by elimination of HCN and elimination of NCHNH (NCHND). The mass spectra of the antiviral agents studied in this paper may be useful in predicting reaction pathways in other heteroaromatic ring decompositions of nucleosides and nucleotides.

Keywords

gas-phase H/D exchange electrospray ionization/collision-induced dissociation mass spectra antiviral agents purine derivatives mechanism of ion formation

Get full access to this article

View all access options for this article.

References

Buchanan

M.V.

Hettich

R.L.

and Stemmler

, Abstracts, 213th ACS National Meeting, San Francisco, ANYL-229. American Chemical Society, Washington, DC, USA (1997).

Zhao

Fuciarelli

A.F.

and Smith

R.D.

, J. Capillary Electrophoresis 3, 111 (1996).

Porsburgh

M.J.

Foster

T.J.

Barth

P.T.

and Coggins

J.R.

, Microbiology 142, 2943 (1996).

M.Y.

and Shen

, J. Liq. Chromatography 17, 773 (1994).

McCloskey

J.A.

, in Mass Spectrometry in the Health and Life Sciences, Ed by Burlingame

A.L.

and Castagnoli

Jr . Elsevier, Amsterdam, The Netherlands, p. 521 (1985).

McCloskey

J.A.

, in Mass Spectrometry in Biomedical Research, Ed by Gaskell

S.J.

John Wiley and Sons, New York, USA, p. 75 (1986).

Crain

P.F.

, Mass Spectrom. Rev. 9, 505 (1990).

Alexander

A.J.

Kebarle

Fuciarelli

A.F.

and Raleigh

J.A.

, Anal. Chem. 59, 2484 (1987).

Sakurai

Matsuo

Kusai

and Nojima

, Rapid Commun. Mass Spectrom. 3, 212 (1989).

10.

Wilson

M.S.

and McCloskey

J.A.

, J. Am. Chem. Soc. 97, 3436 (1975).

11.

Reddy

D.M.

Crain

P.F.

Edmonds

C.G.

Gupta

Hashizume

Stetter

K.O.

Widdel

and McCloskey

J.A.

, Nucleic Acids Res. 20, 5607 (1992).

12.

Gregson

J.M.

and McCloskey

J.A.

, Tetrahedron Letters 34, 6665 (1993).

13.

Liguori

Greco

Sindona

and Uccella

, Org. Mass Spectrom. 25, 459 (1990).

14.

Crow

F.W.

Tomer

K.B.

Gross

M.L.

McCloskey

J.A.

and Bergstrom

D.E.

, Anal. Biochem. 139, 243 (1984).

15.

Gregson

J.M.

and McCloskey

J.A.

, Int. J. Mass Spectrom. Ion Processes 165/166, 475 (1997).

16.

Kralj

Zigon

Kocjan

and Kobe

, Rapid Commun. Mass Spectrom. 11, 273 (1997).

17.

Bartok

Borcsok

Komoroczy

and Sagi

, J. Mass Spectrom. 31, 756 (1996).

18.

Kovacik

Rybar

and Bozoova

, Chemical Papers 48, 415 (1994).

19.

Curcuruto

Tarzia

and Hamdan

, Rapid Commun. Mass Spectrom. 6, 596 (1992).

20.

Nelson

C.C.

and McCloskey

J.A.

, J. Am. Chem. Soc. 114, 3661 (1992).

21.

Porcelli

Marinello

Pagani

Curcuruto

Fontana

and Traldi

, Org. Mass Spectrom. 27, 1225 (1992).

22.

Yamashita

and Fenn

J.B.

, J. Phys. Chem. 88, 4671 (1984).

23.

Bruins

A.P.

Covey

T.R.

and Henion

J.D.

, Anal. Chem. 59, 2642 (1987).

24.

Ikonomou

M.G.

Blades

A.T.

and Kebarle

, Spectrom. 2, 497 (1991).

25.

Loo

J.A.

Udseth

H.R.

and Smith

R.D.

, Rapid Commun. Mass Spectrom. 2, 207 (1988).

26.

Edlund

P.O.

Lee

E.D.

Henion

J.D.

and Budde

W.L.

, Biomed. Env. Mass Spectrom. 18, 233 (1989).

27.

Wang

Y.Y.

Lyttle

M.H.

and Borer

P.N.

, Nucleic Acids Res. 18, 3347 (1990).

28.

Straub

Voyksner

R.D.

and Keever

J.T.

, J. Chromatograph. 627, 173 (1992).

29.

Auriola

Frith

Rogers

M.J.

Koivuniemi

and Monkkonen

, J. Chromatogr. B: Biomedical Science Application 704, 187 (1997).

30.

Smith

D.L.

Schram

K.H.

and McCloskey

J.A.

, Biomed. Mass Spectrom. 10, 269 (1983).

31.

Zirrolli

J.A.

Wheelan

and Murphy

R.C.

, J. Am. Soc. Mass Spectrom. 5, 416 (1994).

32.

Hocart

C.H.

and Schlunegger

U.P.

, Rapid Commun. Mass Spectrom. 3, 249 (1989).

33.

Rodgers

M.T.

Campbell

Marzluff

E.M.

and Beauchamp

J.L.

, Int. J. Mass Spectrom. Ion Processes 137, 121 (1994).

34.

Wolucka

B.A.

Rush

J.S.

Waechter

C.J.

Shibaev

V.N.

and De Hoffmann

, Anal. Biochem. 255, 244 (1998).

35.

Phillips

D.R.

and McCloskey

J.A.

, Int. J. Mass Spectrom. Ion Processes 128, 61 (1993).

36.

Straub

R.F.

and Voyksner

R.D.

, J. Am. Soc. Mass Spectrom. 4, 578 (1993).

37.

Cerny

R.L.

Gross

M.L.

and Grotjahn

, Anal. Biochem. 156, 424 (1986).

38.

McCloskey

J.A.

, Methods in Enzymol. 193, 329 (1990).

39.

Hass

G.W.

Giblin

D.E.

and Gross

M.L.

, Int. J. Mass Spectrom. Ion Processes 172, 25 (1998).

40.

Adejare

and Brown

P.W.

, Anal. Chem. 69, 1525 (1997).

41.

and Harrison

A.G.

, Canadian J. Chem. 73, 1779 (1995).

42.

Feistner

G.J.

and Hsieh

L.L.

, J. Am. Soc. Mass Spectrom. 6, 836 (1995).

43.

Dookeran

N.N.

and Harrison

A.G.

, J. Am. Soc. Mass Spectrom 6, 19 (1995).

44.

Cushnir

J.R.

Naylor

S.H.

and Farmer

P.B.

, Rapid Commun. Mass Spectrom. 4, 426 (1990).

45.

Amin

M.K.

Fouda

H.G.

Brown

and Munson

J. Am. Soc. Mass Spectrom. 13, 543 (2002).

46.

Hemling

M.E.

Conboy

J.J.

Bean

M.F.

Mentzer

and Carr

S.A.

, J. Am. Soc. Mass Spectrom. 5, 434 (1994).

47.

Kamel

A.M.

Brown

P.R.

and Munson

, Anal. Chem. 71, 5481 (1999).

48.

Izatt

R.M.

Christensen

J.J.

and Rytting

J.H.

, Chem. Rev. 71, 439 (1971).

49.

Del Bene

J.E.

, J. Phys. Chem. 87, 367 (1983).

50.

Saenger

, Principles of Nucleic Acid Structure. Springer-Verlag, Berlin, Germany, p. 105 (1984).

51.

Shaw

S.J.

Desiderio

D.M.

Tsuboyama

and McCloskey

J.A.

, J. Am. Chem. Soc. 92, 2510 (1970).

52.

Lonnberg

, in Biocoordination Chem., Ed by Burger and Kalman . Horwood, London, UK, p. 284–346 (1990).

53.

Christensen

J.J.

Rytting

J.H.

and Izatt

R.M.

, Biochem. 9, 4907 (1970).

54.

Izatt

R.M.

Hanssen

L.D.

Rytting

J.H.

and Christensen

J.J.

, J. Am. Chem. Soc. 87, 2760 (1965).

55.

Molecular Modeling and Computational Chemistry Department, Pfizer Inc.

56.

Hunter

E.P.

and Lias

S.G.

, “Proton Affinity Evaluation” in NIST Chemistry WebBook, NIST Standard Reference Database Number 69, Ed by Mallard

W.G.

and Linstrom

P.J.

National Institute of Standards and Technology, Gaithersburg, MD (2001) (http://webbook.nist.gov).

57.

Katrizky

A.R.

and Karelson

, J. Am. Chem. Soc. 113, 1561 (1991).